Sunscreen (SPF) Alternatives

Topical vitamin C — a leave-on antioxidant skincare active applied to the skin, NOT (in this context) an oral vitamin C supplement. As L-ascorbic acid or a stabilized derivative, it has a strong rationale: vitamin C is an essential cofactor for collagen synthesis and a free-radical scavenger that supports photoprotection. Small, vehicle-controlled split-face trials show genuine but modest improvements in wrinkles, skin texture, and pigmentation, and it has a consistent brightening/depigmenting signal. The honest framing: the whole topical-vitamin-C trial base is tiny (a systematic review pooled ~7 studies and ~139 people), formulations are notoriously unstable (they oxidise and lose potency), and most positive trials combine vitamin C with vitamin E, ferulic acid, or other actives — so vitamin-C-alone efficacy is hard to isolate. These are cosmetic appearance outcomes, not health outcomes, and it is not a sunscreen substitute.

A topical cosmetic form of vitamin A — a leave-on skincare active applied to the skin, NOT something you swallow as a supplement and NOT prescription tretinoin. Retinol is the over-the-counter (OTC) member of the retinoid family. In skin it is converted, in two steps, to retinoic acid — the active molecule that binds nuclear retinoid receptors, nudges fibroblasts to make procollagen, and protects existing collagen from UV-driven breakdown. Several small, double-blind, vehicle-controlled facial trials show a genuine but MODEST improvement in fine lines, photodamage, and pigmentation. The catch: OTC retinol is weaker and less proven than prescription tretinoin, only a small fraction of what you apply actually converts to retinoic acid, a focused systematic review judged the OTC-retinol evidence largely untrustworthy, and it commonly causes dryness, peeling, and irritation. The benefit is a cosmetic appearance effect, not a health outcome.

A prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.

Hydrolyzed peptides that rebuild skin elasticity, reduce joint pain, and strengthen bone density — results build over 8-12 weeks.

Type I collagen from fish with smaller peptide size for superior absorption — proven benefits for skin hydration and wrinkle reduction.

A topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route.

The long-standing gold-standard topical skin-lightening agent for melasma and hyperpigmentation — and now a regulated drug, not a cosmetic. Hydroquinone (HQ) competitively inhibits tyrosinase and is toxic to overactive pigment cells. The honest framing: it is the most rigorously studied and most effective topical depigmenter — a large pivotal RCT, a Cochrane review, and recent meta-analyses all use HQ 4% (and the 'Kligman' triple-combination with a retinoid + steroid) as the benchmark that newer agents are measured against and rarely beat. But it carries real liabilities: irritation, rebound pigmentation, and — with prolonged or high-strength use — a disfiguring complication called exogenous ochronosis. For these reasons it was pulled from US over-the-counter sale in 2020 (now prescription-only) and is restricted in the EU and elsewhere. Effective, but for monitored, time-limited medical use.

A newer non-hydroquinone skin-lightening cream for melasma — an aminothiol naturally present in cells, applied to the skin. The honest framing: cysteamine 5% has a genuinely respectable evidence base — multiple double-blind placebo-controlled RCTs and a 2024 meta-analysis show it significantly beats placebo for melasma, and several head-to-head trials pit it against hydroquinone and triple-combination creams. But its ceiling is capped: against hydroquinone it is non-superior (and in one direct comparison actually inferior), trials are small and several share a manufacturer-affiliated author, and its main real-world drawback is tolerability — a characteristic sulfur odor plus erythema/burning. A credible, hydroquinone-free alternative, not a clear upgrade.